The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis.
Lan YeStephan GretenFlorian WegnerJohanna Doll-LeeLea KreyJohanne HeineFlorin GandorAnnemarie VogelLuise BergerDoreen GruberJohannes LevinSabrina KatzdoblerOliver PetersEman DashtiJosef PrillerEike Jakob SpruthAndrea A KühnPatricia KrauseAnnika SpottkeAnja SchneiderAline BeyleOkka KimmichMarkus DonixRobert HaussmannMoritz BrandtElisabeth DinterJens WiltfangBjörn H SchottInga ZerrMathias BährKatharina BuergerDaniel JanowitzRobert PerneczkyBoris-Stephan RauchmannEndy WeidingerEmrah DüzelWenzel GlanzStefan TeipelIngo KilimannIsabel WursterKathrin BrockmannDaniel C HoffmannThomas KlockgetherOlaf KrauseJohannes Hecknull nullGünter U HöglingerMartin KlietzPublished in: Journal of neurology (2024)
MSA patients face a substantial burden of comorbidities, notably in the genitourinary system. This, coupled with increased polypharmacy and potential drug interactions, highlights the complexity of managing MSA patients. Clinicians should carefully consider these factors when devising treatment strategies for MSA patients.